heart failure
Lack of a clear       survival advantage and ongoing misunderstanding of its mechanism of action have       hindered its acceptance as a treatment alternative for patients with end-stage       heart failure.
Lack of a clear       survival advantage and ongoing misunderstanding of its mechanism of action have       hindered its acceptance as a treatment alternative for  @OBJECT$   @PREDICAT$  end-stage        @SUBJECT$ .